PAM
ACOR

Panagora Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Panagora Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-191
Closed -$47K – 2634
2019
Q4 		$47K Sell
191
-27
-12% -$6.81K ﹤0.01% 1939
2019
Q3 		$75K Sell
218
-282
-56% -$153K ﹤0.01% 1899
2019
Q2 		$460K Sell
500
-175
-26% -$215K ﹤0.01% 1455
2019
Q1 		$1.08M Sell
675
-105
-13% -$189K ﹤0.01% 1087
2018
Q4 		$1.46M Sell
780
-6
-0.8% -$13.1K 0.01% 910
2018
Q3 		$1.85M Sell
786
-566
-42% -$1.75M 0.01% 871
2018
Q2 		$4.66M Buy
1,352
+202
+18% +$619K 0.02% 553
2018
Q1 		$3.26M Buy
1,150
+67
+6% +$201K 0.01% 692
2017
Q4 		$2.79M Sell
1,083
-2
-0.2% -$5.69K 0.01% 741
2017
Q3 		$3.08M Buy
1,085
+365
+51% +$962K 0.01% 703
2017
Q2 		$1.7M Buy
720
+693
+2,567% +$1.37M 0.01% 924
2017
Q1 		$68K Sell
27
-91
-77% -$262K ﹤0.01% 1950
2016
Q4 		$267K Sell
118
-446
-79% -$1.06M ﹤0.01% 1645
2016
Q3 		$1.41M Sell
564
-800
-59% -$2.39M 0.01% 1060
2016
Q2 		$4.17M Sell
1,364
-8
-0.6% -$26K 0.02% 611
2016
Q1 		$4.35M Buy
1,372
+49
+4% +$203K 0.02% 616
2015
Q4 		$6.79M Hold
1,323
– – 0.03% 468
2015
Q3 		$4.21M Hold
1,323
– – 0.02% 549
2015
Q2 		$5.29M Sell
1,323
-22
-2% -$85K 0.03% 517
2015
Q1 		$5.37M Buy
1,345
+22
+2% +$101K 0.03% 475
2014
Q4 		$6.49M Buy
1,323
+16
+1% +$68.7K 0.03% 406
2014
Q3 		$5.32M Sell
1,307
-21
-2% -$78.8K 0.03% 471
2014
Q2 		$5.37M Buy
+1,328
New +$5.42M 0.03% 496

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Panagora Asset Management's ACOR Position: Q1 2020 in Review

Panagora Asset Management sold out of Acorda Therapeutics (ACOR) in Q1 2020, closing a stake of 191 shares — an estimated $47K sold.

Panagora Asset Management first reported a position in ACOR in Q2 2014 and held it in 23 quarters. The position peaked at $6.79M in Q4 2015. 106 funds tracked by Wall St. Rank hold ACOR as of Q1 2020.

  • Panagora Asset Management reported no remaining Acorda Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Panagora Asset Management sold 191 Acorda Therapeutics shares in Q1 2020, an estimated $47K.
  • Panagora Asset Management first reported a position in Acorda Therapeutics in Q2 2014 and held it in 23 quarters.
  • Panagora Asset Management's Acorda Therapeutics position peaked at $6.79M in Q4 2015.
  • 106 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2020.

Based on Panagora Asset Management's 13F filing for Q1 2020, filed 14 May 2020.